SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-20-017195
Filing Date
2020-07-10
Accepted
2020-07-10 15:06:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea124065-13gleviston_innova.htm SC 13G 40127
  Complete submission text file 0001213900-20-017195.txt   41773
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Subject) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-88303 | Film No.: 201022973
SIC: 2834 Pharmaceutical Preparations

Mailing Address 708 THIRD AVENUE, 6TH FLOOR NEW YORK NY 10017
Business Address 708 THIRD AVENUE, 6TH FLOOR NEW YORK NY 10017 646-317-5070
Leviston Resources LLC (Filed by) CIK: 0001731368 (see all company filings)

IRS No.: 821092151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G